Department of Cardiothoracic Surgery, the First Affiliated Hospital of Guangzhou Medical College
Guangzhou, Guangdong, 510120, China
Location status: Recruiting
NCT Number: NCT06988943
Low-dose CT (LDCT)can detect and treat lung cancer earlier and more quickly, while expanded screening coverage helps reduce the incidence and mortality of respiratory diseases such as lung cancer. This study aims to conduct a single-arm cluster randomized trial of digitally enabled LDCT in Guangzhou to assess its intervention effectiveness and cost-effectiveness.
Interested in participating?
Request Info40 year–74 year
All sexes
Interventional
Not applicable
Guangzhou, Guangdong, 510120, China
Location status: Recruiting
This study uses a single-arm design to assign community health service centers in two districts of Guangzhou (Liwan and Baiyun) to the intervention group. A historical self-comparison design is employed. The intervention measures utilize a digital empowerment model for lung cancer screening, which includes the following components: ① Digital health platform: Each street and community health center manages resident information through the Lung Health mini-program; ② AI-based full-lung model reading system: Using artificial intelligence technology to assist in interpreting CT images; ③ Low-dose CT screening: Low-dose CT screening is conducted at primary healthcare institutions, and patients with detected lung nodules are referred to hospitals for further examination. The sampling method used is Probability Proportional to Size (PPS), with an expected sample size of 16000. Participants will complete the "Lung Cancer Health Questionnaire" to collect individual-level confounding factors. Screening data will be collected through the "Fei'anxin" mini-program, and diagnostic data will be provided by designated hospitals and the First Affiliated Hospital of Guangzhou Medical University. The primary outcome of the study is the proportion of early-stage lung cancer in the screening population, defined as the number of early-stage lung cancer cases divided by the total number of people screened. An economic evaluation of the lung cancer CT screening will also be conducted.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
1.Community Health Service Centers (Cluster Level)
The center must manage a population of over 10,000 elderly individuals. The center should be equipped with at least one CT machine and have qualified medical personnel, such as radiologists, radiologic technicians, and nursing staff.
Community health service centers where researchers cannot collect data or conduct follow-up.
Able to understand and willing to sign the informed consent form, and able to participate in long-term follow-up.
Individuals unable to understand the study protocol or who cannot provide informed consent due to cognitive impairments.
Individuals participating in other clinical trials that may affect the results of this study.
Individuals unable to undergo follow-up.
Low-dose CT screening is conducted at primary healthcare institutions, and patients with detected lung nodules are referred to hospitals for further examination
Using artificial intelligence technology to assist in the interpretation of CT images
Community health centers and streets in Guangzhou use a program called "Fei Anxin" to manage residents' information in a unified way
Time frame: Within 1 year after the intervention is implemented
Time frame: Within 1 year after the intervention is implemented
Time frame: Within one year after the intervention is implemented
Time frame: Within three months after the intervention is implemented
Time frame: Within 1 year after the intervention is implemented
Time frame: Within 1 year after the intervention is implemented
Time frame: Within 1 year after the intervention is implemented
Time frame: Within 1 year after the intervention is implemented
Time frame: Within 1 year after the intervention is implemented
Time frame: Within 1 year after the intervention is implemented
Time frame: Within 1 year after the intervention is implemented
Contact information is provided by the study sponsor or research team.
The First Affiliated Hospital of Guangzhou Medical University
Other
Construction and Evaluation of a Hospital-Community Health Collaboration Model Empowered by Digital Technology for Lung Cancer Screening
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06177925
Bronchial Diseases, Bronchial Neoplasms
Guangzhou, China
View Trial DetailsNCT06494241
Bronchial Diseases, Bronchial Neoplasms
Anning, China
View Trial DetailsNCT06376084
Bronchial Diseases, Bronchial Neoplasms
Shanghai, China
View Trial DetailsNCT06004440
Lung Cancer, Lung Diseases
Orlando, Florida, United States
View Trial Details